vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and FREQUENCY ELECTRONICS INC (FEIM). Click either name above to swap in a different company.
ENANTA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($18.6M vs $17.1M, roughly 1.1× FREQUENCY ELECTRONICS INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -64.1%, a 74.6% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs 8.3%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-11.8M). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs 4.5%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
ENTA vs FEIM — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $18.6M | $17.1M |
| Net Profit | $-11.9M | $1.8M |
| Gross Margin | — | 38.2% |
| Operating Margin | -60.5% | 10.0% |
| Net Margin | -64.1% | 10.5% |
| Revenue YoY | 9.8% | 8.3% |
| Net Profit YoY | 46.4% | -32.1% |
| EPS (diluted) | $-0.42 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $17.1M | ||
| Q3 25 | $15.1M | $13.8M | ||
| Q2 25 | $18.3M | $20.0M | ||
| Q1 25 | $14.9M | $18.9M | ||
| Q4 24 | $17.0M | $15.8M | ||
| Q3 24 | $14.6M | $15.1M | ||
| Q2 24 | $18.0M | $15.6M | ||
| Q1 24 | $17.1M | $13.7M |
| Q4 25 | $-11.9M | $1.8M | ||
| Q3 25 | $-18.7M | $634.0K | ||
| Q2 25 | $-18.3M | $3.2M | ||
| Q1 25 | $-22.6M | $15.4M | ||
| Q4 24 | $-22.3M | $2.7M | ||
| Q3 24 | $-28.8M | $2.4M | ||
| Q2 24 | $-22.7M | $2.6M | ||
| Q1 24 | $-31.2M | $130.0K |
| Q4 25 | — | 38.2% | ||
| Q3 25 | — | 36.8% | ||
| Q2 25 | — | 37.5% | ||
| Q1 25 | — | 43.8% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | — | 44.4% | ||
| Q2 24 | — | 40.3% | ||
| Q1 24 | — | 22.6% |
| Q4 25 | -60.5% | 10.0% | ||
| Q3 25 | -121.6% | 2.6% | ||
| Q2 25 | -103.2% | 16.4% | ||
| Q1 25 | -164.3% | 18.3% | ||
| Q4 24 | -138.8% | 16.5% | ||
| Q3 24 | -204.4% | 15.7% | ||
| Q2 24 | -134.6% | 16.0% | ||
| Q1 24 | -192.1% | -3.4% |
| Q4 25 | -64.1% | 10.5% | ||
| Q3 25 | -123.6% | 4.6% | ||
| Q2 25 | -99.7% | 16.0% | ||
| Q1 25 | -151.7% | 81.4% | ||
| Q4 24 | -131.4% | 16.8% | ||
| Q3 24 | -197.3% | 16.1% | ||
| Q2 24 | -126.1% | 16.9% | ||
| Q1 24 | -182.7% | 0.9% |
| Q4 25 | $-0.42 | $0.18 | ||
| Q3 25 | $-0.88 | $0.07 | ||
| Q2 25 | $-0.85 | $0.33 | ||
| Q1 25 | $-1.06 | $1.60 | ||
| Q4 24 | $-1.05 | $0.28 | ||
| Q3 24 | $-1.36 | $0.25 | ||
| Q2 24 | $-1.07 | $0.28 | ||
| Q1 24 | $-1.47 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $3.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $126.6M | $58.5M |
| Total Assets | $329.5M | $92.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | $3.0M | ||
| Q3 25 | $32.3M | $4.5M | ||
| Q2 25 | $44.8M | $4.7M | ||
| Q1 25 | $60.2M | $5.5M | ||
| Q4 24 | $84.3M | $9.7M | ||
| Q3 24 | $37.2M | $16.2M | ||
| Q2 24 | $35.8M | $18.3M | ||
| Q1 24 | $63.5M | $11.7M |
| Q4 25 | $126.6M | $58.5M | ||
| Q3 25 | $64.7M | $56.3M | ||
| Q2 25 | $79.3M | $55.6M | ||
| Q1 25 | $93.5M | $51.8M | ||
| Q4 24 | $111.8M | $36.2M | ||
| Q3 24 | $128.8M | $33.2M | ||
| Q2 24 | $148.9M | $39.8M | ||
| Q1 24 | $166.1M | $36.7M |
| Q4 25 | $329.5M | $92.3M | ||
| Q3 25 | $280.7M | $93.2M | ||
| Q2 25 | $301.0M | $93.7M | ||
| Q1 25 | $323.0M | $86.4M | ||
| Q4 24 | $348.6M | $77.8M | ||
| Q3 24 | $376.7M | $84.3M | ||
| Q2 24 | $398.8M | $83.3M | ||
| Q1 24 | $413.6M | $77.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $-523.0K |
| Free Cash FlowOCF − Capex | $-11.8M | $-1.1M |
| FCF MarginFCF / Revenue | -63.6% | -6.6% |
| Capex IntensityCapex / Revenue | 0.8% | 3.6% |
| Cash ConversionOCF / Net Profit | — | -0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $-523.0K | ||
| Q3 25 | $-6.5M | $1.2M | ||
| Q2 25 | $17.5M | $-155.0K | ||
| Q1 25 | $-13.5M | $-3.6M | ||
| Q4 24 | $-16.8M | $3.8M | ||
| Q3 24 | $-10.4M | $-1.5M | ||
| Q2 24 | $-14.8M | $7.5M | ||
| Q1 24 | $-28.6M | $4.2M |
| Q4 25 | $-11.8M | $-1.1M | ||
| Q3 25 | $-7.9M | $385.0K | ||
| Q2 25 | $17.4M | $-786.0K | ||
| Q1 25 | $-16.0M | $-4.0M | ||
| Q4 24 | $-25.5M | $3.3M | ||
| Q3 24 | $-19.4M | $-1.8M | ||
| Q2 24 | $-21.3M | $6.7M | ||
| Q1 24 | $-30.3M | $3.9M |
| Q4 25 | -63.6% | -6.6% | ||
| Q3 25 | -52.5% | 2.8% | ||
| Q2 25 | 94.7% | -3.9% | ||
| Q1 25 | -107.4% | -20.9% | ||
| Q4 24 | -150.6% | 20.8% | ||
| Q3 24 | -132.5% | -11.8% | ||
| Q2 24 | -118.6% | 42.8% | ||
| Q1 24 | -177.5% | 28.4% |
| Q4 25 | 0.8% | 3.6% | ||
| Q3 25 | 9.6% | 5.6% | ||
| Q2 25 | 0.8% | 3.2% | ||
| Q1 25 | 17.0% | 1.7% | ||
| Q4 24 | 51.6% | 3.3% | ||
| Q3 24 | 61.3% | 2.2% | ||
| Q2 24 | 36.4% | 5.3% | ||
| Q1 24 | 9.8% | 2.3% |
| Q4 25 | — | -0.29× | ||
| Q3 25 | — | 1.83× | ||
| Q2 25 | — | -0.05× | ||
| Q1 25 | — | -0.24× | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | -0.60× | ||
| Q2 24 | — | 2.85× | ||
| Q1 24 | — | 32.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTA
Segment breakdown not available.
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |